tiprankstipranks
Advertisement
Advertisement
ENTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsENTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Why the World’s Leading Healthcare Funds All Wanted a Piece of Entera Bio (NASDAQ: ENTX)
Premium
TipRanks Newswire
Why the World’s Leading Healthcare Funds All Wanted a Piece of Entera Bio (NASDAQ: ENTX)
1M ago
Entera Bio Raises $275M in Strategic Private Placement
Premium
Company Announcements
Entera Bio Raises $275M in Strategic Private Placement
1M ago
America’s Osteoporosis Crisis and the Oral Peptide Player You Should Watch (NASDAQ: ENTX)
PremiumTipRanks NewswireAmerica’s Osteoporosis Crisis and the Oral Peptide Player You Should Watch (NASDAQ: ENTX)
2M ago
Entera Bio: Buy Rating Reiterated on De-Risked Oral PTH Platform and FDA-Supported Phase 3 Design; $9 Price Target Maintained
Premium
Ratings
Entera Bio: Buy Rating Reiterated on De-Risked Oral PTH Platform and FDA-Supported Phase 3 Design; $9 Price Target Maintained
3M ago
Entera Bio gets FDA feedback on registrational protocol for EB613
Premium
The Fly
Entera Bio gets FDA feedback on registrational protocol for EB613
3M ago
Entera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions
PremiumCompany AnnouncementsEntera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions
4M ago
Entera Bio files to sell 19.57M ordinary shares for holders
Premium
The Fly
Entera Bio files to sell 19.57M ordinary shares for holders
4M ago
Entera Bio Highlights Q1 2026 Progress and Financing
Premium
Company Announcements
Entera Bio Highlights Q1 2026 Progress and Financing
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100